Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- Check5 days agoChange DetectedAdded a Results and Publications section with the NEJM publication and associated outcomes.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision label updated to v3.5.0 (previously v3.4.3).SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedRevision bump: v3.4.2 has been added and v3.4.1 removed, indicating a minor platform update with no visible changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; there are no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Glossary display and updated metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision to v3.4.0. Removed older Last Update Submitted that Met QC Criteria, No FEAR Act data, and revision v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.